{name}
{subtitle}
Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy
city
~10 mi. (Chermside, Australia, +55 more cities)
facility
The Prince Charles Hospital (Adults only)
drug type
cellular therapy, +1 more type
Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer
city
~15 mi. (Herston, Australia, +247 more cities)
facility
Royal Brisbane and Womens Hospital
biomarker
ER Positive, +1 more biomarker
drug
anthracycline, +4 more drugs
drug type
chemotherapy, +2 more types
Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)
city
~15 mi. (Herston, Australia, +147 more cities)
facility
Royal Brisbane and Women s Hospital ( Site 0972)
condition
Cervical Adenocarcinoma, +2 more conditions
drug
brachytherapy, +3 more drugs
drug type
chemotherapy, +2 more types
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
city
~15 mi. (Herston, Australia, +127 more cities)
facility
Royal Brisbane & Women's Hospital
drug
cetuximab, +3 more drugs
drug type
chemotherapy, +1 more type
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
city
~15 mi. (Herston, Australia, +150 more cities)
facility
Royal Brisbane and Women s Hospital ( Site 0050)
drug
cisplatin, +2 more drugs
drug type
chemotherapy, +2 more types
Efficacy and Safety of Olaparib (MK-7339) With or Without Bevacizumab Compared to Bevacizumab With a Fluoropyrimidine in Unresectable or Metastatic Colorectal Cancer (CRC) (MK-7339-003/LYNK-003)
city
~15 mi. (Herston, Australia, +105 more cities)
facility
Royal Brisbane and Women s Hospital ( Site 0054)
drug
bevacizumab, +1 more drug
A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)
city
~15 mi. (Herston, Australia, +35 more cities)
facility
Royal Brisbane and Women s Hospital ( Site 0058)
drug
favezelimab, +1 more drug